Table 1 Patient characteristics according to NLR (<5 or ≥5) in this study (n = 63).
All patients | NLR < 5 n = 47 | NLR ≥ 5 n = 16 | p | |
|---|---|---|---|---|
Age, median (range), in years | 62 (28–79) | 63 (28–79) | 62 (48–79) | |
Age, n (%) | ||||
<75 years | 56 (88.9) | 42 (89.4) | 14 (87.5) | |
≥75 years | 7 (11.1) | 5 (10.6) | 2 (12.5) | 1.00* |
Gender, n (%) | ||||
Male | 55 (87.3) | 41 (87.2) | 14 (87.5) | |
Female | 8 (12.7) | 6 (12.8) | 2 (12.5) | 1.00* |
Smoking status, n (%) | ||||
Never | 4 (6.3) | 3 (6.4) | 1 (6.2) | |
Former/current | 59 (93.7) | 44 (93.6) | 15 (93.8) | 1.00* |
ECOG PS, n (%) | ||||
0–1 | 60 (95.2) | 46 (97.8) | 14 (87.5) | |
2/3–4 | 3 (4.8)/0 (0) | 1 (2.2)/0 (0.0) | 2 (12.5)/0 (0.0) | 0.16* |
Stage, n (%) | ||||
IIIB | 6 (9.5) | 5 (10.6) | 1 (6.2) | |
IV | 30 (47.6) | 21 (44.7) | 9 (56.3) | |
Recurrence | 27 (42.9) | 21 (44.7) | 6 (37.5) | 0.77* |
Brain metastasis, n (%) | ||||
Yes | 14 (22.2) | 8 (17.1) | 6 (37.5) | |
No | 49 (77.8) | 39 (82.9) | 10 (62.5) | 0.16* |
Blood tests, average ± SD | ||||
Alb, g/dL | 3.9 ± 0.5 | 4.0 ± 0.4 | 3.5 ± 0.6 | 0.01** |
LDH, IU/L | 473 ± 707 | 389 ± 400 | 719 ± 1219 | 0.31** |
CRP, mg/dL | 1.7 ± 3.4 | 0.8 ± 1.5 | 4.4 ± 5.6 | 0.02** |
NSE, ng/mL | 47.3 ± 67.0 | 46.4 ± 74.1 | 46.9 ± 40.7 | 0.86** |
Pro-GRP, pg/mL | 704 ± 3757 | 893 ± 4350 | 158 ± 444 | 0.50** |
